Company: MDCXW
Filing Date: 2025-06-02
Form Type: 8-K
Source: 0001062993-25-010687
Chunk: 2

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-02
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

On May 29, 2025, the Company issued a press release announcing the pricing of the Offering and on June 2, 2025, the Company issued a press release announcing the closing of the Offering. Copies of the press releases are attached hereto as Exhibits 99.1 and 99.2, respectively, and incorporated by reference herein.

As previously disclosed in that certain Current Report on Form 8-K filed by the Company on May 5, 2025, the Company entered into a securities purchase agreement (the "Purchase Agreement") with YA II PN, Ltd. ("Yorkville") on May 2, 2025, in connection with the issuance and sale by the Company of debentures (the "Debentures") issuable in an aggregate principal amount of up to $5,000,000. Yorkville purchased and the Company issued a Debenture in aggregate principal amount of $1,250,000 upon the signing of the Purchase Agreement, for net proceeds to the company of $1,125,000. On June 2, 2025, Yorkville purchased and the Company issued an additional Debenture in the aggregate principal amount of $1,250,000, in connection with the filing of the Company's Registration Statement on May 27, 2025, for additional net proceeds to the Company of $1,125,000.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                                           
  No.                                                                                                                                                                                                                
  1.1*         Placement Agency Agreement, dated as of May 29, 2025, by and between Medicus Pharma Ltd. and Maxim Group LLC as representative of the placement agents named therein                                  
  4.1          Form of Subscription Agreement (incorporated by reference from Exhibit 4.8 to the Company's Registration Statement on Form S-1, filed with the SEC on May 27, 2025)                                   
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  4.2*         Common Share Purchase Warrant                                                                                                                                                                         
  4.3*#        Warrant Agency Agreement, dated as of June 2, 2025, by and between Medicus Pharma Ltd. and Odyssey Transfer and Trust Company, as warrant agent                                                       
  99.1